Apalcillin

This classification denotes a penicillin antibiotic with the molecular formula C25H23N5O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3373RT9U7A, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-hydroxy-1,5-naphthyridin-3-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2-alpha,5-alpha,6-beta(s*)))- but generally known as apalcillin, which bears US NIH Compound Identifier 107947. Apalcillin most often comes in base and sodium forms. European Medicines Agency schedules Apalcillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05535MIG. The term APALCILLIN is an International Non-Proprietary Name. APALCILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule apalcillin under HS 29411090 and SITC 54131. As of Q4 2014, APALCILLIN remains the US FDA Preferred Term for this commodity. Apalcillin bears US NLM identifiers UMLS ID C0052145 and NCI Concept Code C76217. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C(NC(=O)C1C(=O)C2NCCCC2[NH]C1)C1CCCCC1.